2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …

G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

MicroRNAs in atrial fibrillation: Pathophysiological aspects and potential biomarkers

AM Chaulin, DV Duplyakov - International Journal of Biomedicine, 2020 - elibrary.ru
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia associated with
increased morbidity and mortality. The pathophysiological mechanisms underlying the …

MicroRNAs and atrial fibrillation: new fundamentals

Z Wang, Y Lu, B Yang - Cardiovascular research, 2011 - academic.oup.com
Atrial fibrillation (AF) is the most commonly encountered clinical arrhythmia associated with
pronounced morbidity, mortality, and socio-economic burden. This pathological entity is …

MicroRNAs in atrial fibrillation: from expression signatures to functional implications

NWE van den Berg, M Kawasaki, WR Berger… - … Drugs and Therapy, 2017 - Springer
Atrial fibrillation (AF) is the most common sustained arrhythmia and is associated with
pronounced morbidity and mortality. Its prevalence, expected to further increase for the …

[HTML][HTML] MicroRNAs: Emerging biomarkers for atrial fibrillation

S Komal, JJ Yin, SH Wang, CZ Huang, HL Tao… - Journal of …, 2019 - Elsevier
Atrial fibrillation (AF) causes severe cardiac dysrhythmia among patients with cardiovascular
diseases. AF increases the risk of stroke and heart failure and is a growing public health …

MicroRNAs and atrial fibrillation: mechanisms and translational potential

X Luo, B Yang, S Nattel - Nature Reviews Cardiology, 2015 - nature.com
Atrial fibrillation (AF), the most common sustained arrhythmia in clinical practice, is an
important contributor to cardiac morbidity and mortality. Pharmacological approaches …

The expression levels of plasma micoRNAs in atrial fibrillation patients

Z Liu, C Zhou, Y Liu, S Wang, P Ye, X Miao, J Xia - 2012 - journals.plos.org
Background MicroRNA (miRNA) has been found in human blood. It has been increasingly
suggested that miRNAs may serve as biomarkers for diseases. We examined the potential of …

MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets

P Silvestri, C Di Russo, S Rigattieri… - Recent Patents on …, 2009 - ingentaconnect.com
MicroRNAs are key, recently discovered, regulators of gene expression. They are involved
in many physiological cellular pathways so it is not surprising that an altered microRNA …

MicroRNAs: novel regulators in cardiac development and disease

T Thum, D Catalucci, J Bauersachs - Cardiovascular research, 2008 - academic.oup.com
MicroRNAs (miRNAs) are endogenous, small ribonucleotides regulating the translation of
target messenger RNAs that have been shown to be involved in orchestrating growth …

The roles of microRNAs in heart diseases: a novel important regulator

BZ Cai, ZW Pan, YJ Lu - Current medicinal chemistry, 2010 - ingentaconnect.com
MicroRNAs (miRNAs) are non-coding single-stranded RNAs with about 21˜ 23 nucleotides
in length, which originate from encoding genes in nucleus. In most cases miRNAs play an …